Cargando…
An anti-TNF-α antibody mimetic to treat ocular inflammation
Infliximab is an antibody that neutralizes TNF-α and is used principally by systemic administration to treat many inflammatory disorders. We prepared the antibody mimetic Fab-PEG-Fab (FpF(infliximab)) for direct intravitreal injection to assess whether such formulations have biological activity and...
Autores principales: | Khalili, Hanieh, Lee, Richard W., Khaw, Peng T., Brocchini, Steve, Dick, Andrew D., Copland, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118814/ https://www.ncbi.nlm.nih.gov/pubmed/27874029 http://dx.doi.org/10.1038/srep36905 |
Ejemplares similares
-
Comparative thermodynamic analysis in solution of a next generation antibody mimetic to VEGF
por: Khalili, Hanieh, et al.
Publicado: (2018) -
An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
por: Mohamed-Ahmed, Abeer H. A., et al.
Publicado: (2017) -
Real-Time Monitoring Platform for Ocular Drug Delivery
por: Awwad, Sahar, et al.
Publicado: (2023) -
Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study
por: Sharma, Srilakshmi M, et al.
Publicado: (2021) -
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling
por: Shibuya, Yusuke, et al.
Publicado: (2023)